These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29854384)

  • 1. Serum Homocysteine Level in Parkinson's Disease and Its Association with Duration, Cardinal Manifestation, and Severity of Disease.
    Saadat P; Ahmadi Ahangar A; Samaei SE; Firozjaie A; Abbaspour F; Khafri S; Khoddami A
    Parkinsons Dis; 2018; 2018():5813084. PubMed ID: 29854384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson's Disease.
    Bakeberg MC; Jefferson A; Riley M; Byrnes M; Ghosh S; Mastaglia FL; Horne MK; McGregor S; Stell R; Kenna J; Walters S; Hince D; Anderton RS
    Parkinsons Dis; 2019; 2019():3124295. PubMed ID: 31275543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease.
    Kirbas S; Kirbas A; Tufekci A; Cumhur Cure M; Cakmak S; Yazici T; Cure E
    Acta Clin Belg; 2016 Apr; 71(2):71-5. PubMed ID: 27075796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease.
    Li J; Gu C; Zhu M; Li D; Chen L; Zhu X
    Psychogeriatrics; 2020 Mar; 20(2):180-188. PubMed ID: 31828903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
    Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
    West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.
    Sleeman I; Lawson RA; Yarnall AJ; Duncan GW; Johnston F; Khoo TK; Burn DJ
    J Parkinsons Dis; 2019; 9(2):351-359. PubMed ID: 30909247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson's disease.
    Yang Y; Gao F; Gao L; Miao J
    BMC Neurol; 2023 Oct; 23(1):360. PubMed ID: 37803329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum B12, Homocysteine Levels, and their Effect on Peripheral Neuropathy in Parkinson's Disease: Indian Cohort.
    Mathukumalli NL; Kandadai MR; Shaik JA; Kanikannan MA; Borgohain R
    Ann Indian Acad Neurol; 2020; 23(1):48-53. PubMed ID: 32055122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between homocysteine and third ventricle dilatation, mesencephalic area atrophy in Parkinson's disease with cognitive impairment.
    Fu XY; Zhang YC; Ding CW; Yang M; Song X; Wang CS; Chen XF; Zhang Y; Sheng YJ; Mao P; Mao CJ; Liu CF
    J Clin Neurosci; 2021 Aug; 90():273-278. PubMed ID: 34275563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum homocysteine and physical exercise in patients with Parkinson's disease.
    Nascimento CM; Stella F; Garlipp CR; Santos RF; Gobbi S; Gobbi LT
    Psychogeriatrics; 2011 Jun; 11(2):105-12. PubMed ID: 21707858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.
    Zoccolella S; dell'Aquila C; Abruzzese G; Antonini A; Bonuccelli U; Canesi M; Cristina S; Marchese R; Pacchetti C; Zagaglia R; Logroscino G; Defazio G; Lamberti P; Livrea P
    Mov Disord; 2009 May; 24(7):1028-33. PubMed ID: 19353704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE CORRELATION BETWEEN SERUM HOMOCYSTEINE LEVEL AND PARKINSON'S DISEASE DISABILITY.
    Taher Y; Natheer M; Majdal H
    Georgian Med News; 2022 Oct; (331):36-41. PubMed ID: 36539128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of Plasma Homocysteine, Vitamin B12, and Folate in Parkinson's Disease: An Updated Meta-Analysis.
    Liu Y; Gou M; Guo X
    J Integr Neurosci; 2023 Aug; 22(5):115. PubMed ID: 37735121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Uric Acid, Serum Uric Acid to Serum Creatinine Ratio and Serum Bilirubin in Patients With Parkinson's Disease: A Case-Control Study.
    Songsomboon C; Tanprawate S; Soontornpun A; Wantaneeyawong C; Louthrenoo W
    J Clin Med Res; 2020 Mar; 12(3):172-179. PubMed ID: 32231753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine in relation to cognitive performance in pathological and non-pathological conditions.
    Teunissen CE; van Boxtel MP; Jolles J; de Vente J; Vreeling F; Verhey F; Polman CH; Dijkstra CD; Blom HJ
    Clin Chem Lab Med; 2005; 43(10):1089-95. PubMed ID: 16197303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine levels, genetic background, and cognitive impairment in Parkinson's disease.
    Periñán MT; Macías-García D; Jesús S; Martín-Rodríguez JF; Muñoz-Delgado L; Jimenez-Jaraba MV; Buiza-Rueda D; Bonilla-Toribio M; Adarmes-Gómez AD; Gómez-Garre P; Mir P
    J Neurol; 2023 Jan; 270(1):477-485. PubMed ID: 36169739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of homocysteine in the development and progression of Parkinson's disease.
    Fan X; Zhang L; Li H; Chen G; Qi G; Ma X; Jin Y
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2332-2338. PubMed ID: 33085841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Xie Y; Feng H; Peng S; Xiao J; Zhang J
    Neurosci Lett; 2017 Jan; 636():190-195. PubMed ID: 27840145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of entacapone on plasma homocysteine in Parkinson's disease patients on levodopa].
    Zhao P; Yang JF; Liu W; Wang Y; Sun YN; Li Q; Zhang W; Zhang BS
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):512-5. PubMed ID: 23660319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.